Protein phosphatases in the regulation of mitosis
J Nilsson - Journal of Cell Biology, 2019 - rupress.org
The accurate segregation of genetic material to daughter cells during mitosis depends on
the precise coordination and regulation of hundreds of proteins by dynamic phosphorylation …
the precise coordination and regulation of hundreds of proteins by dynamic phosphorylation …
[HTML][HTML] Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
AR Clark, M Ohlmeyer - Pharmacology & therapeutics, 2019 - Elsevier
Abstract Protein phosphatase 2A (PP2A) is a highly complex heterotrimeric enzyme that
catalyzes the selective removal of phosphate groups from protein serine and threonine …
catalyzes the selective removal of phosphate groups from protein serine and threonine …
Selective PP2A enhancement through biased heterotrimer stabilization
Impairment of protein phosphatases, including the family of serine/threonine phosphatases
designated PP2A, is essential for the pathogenesis of many diseases, including cancer. The …
designated PP2A, is essential for the pathogenesis of many diseases, including cancer. The …
Retracted: allosteric activators of protein phosphatase 2a display broad antitumor activity mediated by dephosphorylation of MYBL2
SUMMARY Protein phosphatase 2A (PP2A) enzymes can suppress tumors, but they are
often inactivated in human cancers overexpressing inhibitory proteins. Here, we identify a …
often inactivated in human cancers overexpressing inhibitory proteins. Here, we identify a …
Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway
R A. Avelar, R Gupta, G Carvette… - Cell Death & …, 2024 - nature.com
The integrated stress response (ISR) regulates cell fate during conditions of stress by
leveraging the cell's capacity to endure sustainable and efficient adaptive stress responses …
leveraging the cell's capacity to endure sustainable and efficient adaptive stress responses …
Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics
Dysregulated expression and activity of cathepsin S (CTSS), a lysosomal protease and a
member of the cysteine cathepsin protease family, is linked to the pathogenesis of multiple …
member of the cysteine cathepsin protease family, is linked to the pathogenesis of multiple …
Challenges and opportunities for therapeutic targeting of calmodulin kinase II in heart
Heart failure remains a major health burden around the world. Despite great progress in
delineation of molecular mechanisms underlying development of disease, standard therapy …
delineation of molecular mechanisms underlying development of disease, standard therapy …
Small-molecule–mediated stabilization of PP2A modulates the homologous recombination pathway and potentiates DNA damage-induced cell death
RA Avelar, AJ Armstrong, G Carvette, R Gupta… - Molecular cancer …, 2023 - AACR
High-grade serous carcinoma (HGSC) is the most common and lethal ovarian cancer
subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy …
subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy …
[HTML][HTML] Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex
X He, M Li, H Yu, G Liu, N Wang, C Yin, Q Tu… - PLoS …, 2020 - journals.plos.org
Loss of hepatic fructose-1, 6-bisphosphate aldolase B (Aldob) leads to a paradoxical up-
regulation of glucose metabolism to favor hepatocellular carcinogenesis (HCC), but the …
regulation of glucose metabolism to favor hepatocellular carcinogenesis (HCC), but the …
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP 2A strikes back
J Westermarck - The FEBS journal, 2018 - Wiley Online Library
Therapies targeting tyrosine and serine/threonine kinases have raised enormous interest as
potential cure for cancer patients in many common cancer types. However, except for the …
potential cure for cancer patients in many common cancer types. However, except for the …